604.691.6830
Financings and going public transactions
- Acted for Amorfix Life Sciences Ltd. in private placements of 2,750,000 common shares and 2,750,000 warrants of Amorfix, for total proceeds of $850,000.
- Acted for Sirona Biochem Corp. in private placements of 17,995,000 common shares and 17,995,000 warrants of Sirona, for total proceeds of $1,799,500.
- Spanish Mountain Gold Ltd. non-brokered private placement of equity securities for gross proceeds of $20 million.
- Silvermex Resources Inc. brokered private placement for gross proceeds of $15 million (lead agent: MGI Securities Inc.).
- Richfield Ventures Corp. private placements of equity securities with institutional investors for gross proceeds of $14.625 million (finder: Axemen Resource Capital) and $7.5M (agent: Loewen, Ondaatje, McCutcheon Limited).
- Amorfix Life Sciences $10M bought deal and subsequent TSX Listing (underwriter and sponsor: Versant Partners).
- Qualifying Transaction on TSX Venture Exchange by Richfield Ventures Corp.
- Initial public offerings by Western Pacific Resources Corp. (agent: Canaccord Financial); Central Resources Corp. (agent: Research Capital); Riverside Resources Inc. (agent: Canaccord Capital).
- Reverse takeovers by way of an amalgamation of a biotechnology company on the TSX Venture Exchange and by way of an exempt take-over bid of a technology company on the TSX Venture Exchange.
Mergers and acquisitions
- Acted for Silvermex Resources Inc. (TSX) in its acquisition by First Majestic Silver Corporation by way of a plan of arrangement, with the transaction valued at $175 million.
- Acted for Kombat Copper Inc. (TSX-V) in its $13 million subscription receipts private placement (agent: Dundee Securities Ltd.) and related acquisition of Kombat Copper Project.
- Acquisition of Richfield Ventures Corp. by New Gold Inc. through a plan of arrangement, valued at approximately $550 million.
- Business combination of Silvermex Resources Ltd. and Genco Resources Ltd. becoming Silvermex Resources Inc., a silver and gold producer, valued at approximately $140 million.
- Acquisition of a private technology company client by a US-based NASDAQ issuer.
- Acquisition of a private biotechnology company by a German company listed on the Frankfurt Stock Exchange, by way of a three-cornered amalgamation under the laws of Delaware.
- Acquisition of a TSX Venture resource issuer by a US-based TSX issuer, through a plan of arrangement that included the spin-out of a new public company.
- Acquisition of a mining operation in Mexico by a TSX Venture issuer from a TSX issuer, through share purchase of the subsidiary.
- Reorganization of private technology corporation to transfer assets from Canadian corporation to subsidiary of Delaware corporation to facilitate US venture participation.
Joint ventures, alliances and collaborations
- Alliances, earn-ins, options, joint ventures and shareholder agreements for numerous exploration and development mineral resource and mining projects in various jurisdictions, including projects located in North America, South America and Africa.
- Joint ventures effected through territorial licensing and engineering supply agreements for technology and plant to convert bio-mass to bio-oil.
- Research and product development collaboration agreements, including development collaborations involving equity investments and options to license technology to commercialize therapeutics.
Regulatory
- While at the British Columbia Securities Commission, Gary advised, in respect of, and drafted various forms of securities regulation, including the Rights Offering Instrument, Short Form Offering Instrument, Integrated Disclosure System Concept Proposal, and the rules, blanket orders, interpretation notes and policies relating to the restructuring of Canadian stock exchanges in 1999.
